TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
32
|
259
|
160 |
Financial expenses |
0
|
49
|
0 |
Earnings before taxes |
301
|
108
|
76 |
EBITDA |
-49
|
156
|
76 |
Total assets |
716
|
436
|
340 |
Current assets |
716
|
436
|
340 |
Current liabilities |
328
|
233
|
239 |
Equity capital |
388
|
203
|
101 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.2%
|
46.6%
|
29.7% |
Turnover per employee |
32
|
259
|
160 |
Profit as a percentage of turnover |
940.6%
|
41.7%
|
47.5% |
Return on assets (ROA) |
42.0%
|
36.0%
|
22.4% |
Current ratio |
218.3%
|
187.1%
|
142.3% |
Return on equity (ROE) |
77.6%
|
53.2%
|
75.2% |
Change turnover |
-227
|
99
|
160 |
Change turnover % |
-88%
|
62% | |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.